What Vitamins Help Reduce Eye Pressure?

No vitamin has been proven to lower eye pressure reliably enough to replace standard glaucoma medications, but a handful of nutrients show genuine promise in early research. Vitamin C metabolites, vitamin D, and B-group vitamins (particularly nicotinamide, the amide form of B3) have the strongest signals so far, each working through different pathways. The picture gets more complicated once you separate actual pressure reduction from neuroprotection, which shields the optic nerve even when pressure stays elevated. Understanding that distinction matters, because a supplement that protects your vision without budging the pressure gauge is still valuable.

Why Eye Pressure Rises in the First Place

Your eye constantly produces a clear fluid called aqueous humor that nourishes its internal structures and then drains out through a spongy tissue called the trabecular meshwork. When that meshwork becomes stiffer or more resistant to flow, fluid backs up and pressure climbs. This resistance naturally increases with age, and it increases further in people with open-angle glaucoma, the most common form of the disease.¹ Elevated intraocular pressure (IOP) is the primary modifiable risk factor for glaucoma, which is the second leading cause of irreversible blindness worldwide.²

Oxidative stress plays a central role in damaging the meshwork. Reactive oxygen molecules accumulate over years, degrading the cells that keep the drainage pathway flexible and functional.³ This is why antioxidant vitamins have attracted so much research attention: in theory, reducing oxidative damage could keep the meshwork healthier for longer and slow the pressure increase. Whether that theory pans out at real-world supplement doses is the question each vitamin has to answer individually.

Vitamin C and Its Metabolites

Vitamin C has the most direct mechanistic link to pressure control. A large genetic analysis using data from the UK Biobank found that O-methylascorbate, a circulating metabolite of vitamin C, has a statistically significant inverse relationship with IOP. In other words, as blood levels of this metabolite rose, eye pressure fell. The researchers used Mendelian randomization, a technique that leverages genetic variants to test cause-and-effect relationships, and the association held across all three statistical models they applied.⁴ That makes this one of the stronger pieces of evidence we have for any nutrient and IOP.

Interestingly, a separate Canadian study explored how genetic variants tied to vitamin C metabolites interact with dietary factors like fruit and vegetable intake to influence IOP, suggesting the relationship between vitamin C and eye pressure may depend partly on your genetic background.⁵ Still, a meta-analysis pooling observational studies did not find that high vitamin C intake was significantly associated with lower glaucoma prevalence overall.⁶ That gap between the genetic evidence and the observational data is one reason researchers have not reached a consensus. It could mean the benefit operates through a specific metabolic pathway that simple dietary intake questionnaires fail to capture.

Vitamin B3 and the Nicotinamide Story

If any vitamin has generated genuine excitement in glaucoma research over the past decade, it is nicotinamide, the amide form of vitamin B3. In a widely cited mouse model of inherited glaucoma, nicotinamide supplementation was remarkably protective. At the lowest dose tested, roughly 70% of eyes showed no detectable glaucomatous damage. At the highest dose, 93% of eyes were protected, representing about a tenfold decrease in the risk of developing glaucoma.⁷

Here is where the IOP question gets nuanced. At the lowest dose, nicotinamide had no effect on eye pressure whatsoever. It was purely neuroprotective, shielding retinal ganglion cells by restoring levels of NAD, a molecule essential for mitochondrial energy production that declines with age. At the highest dose, pressure still became elevated, but the degree of elevation was somewhat reduced.⁸ So nicotinamide appears to work primarily by making the optic nerve more resilient to pressure damage, with a modest pressure-lowering bonus at high doses. A recent review noted that at the highest doses tested, nicotinamide lowered IOP by about 1 mmHg in control (but not ocular hypertensive) eyes.⁹

These findings come from mice, not humans, and that distinction matters enormously. Human clinical trials are underway, including a randomized controlled trial testing a vitamin mix that includes nicotinamide alongside standard pressure-lowering therapy.¹⁰ Until those results come in, nicotinamide remains highly promising but unproven in people.

One important safety note: niacin (nicotinic acid), a different form of vitamin B3, has been linked to cystoid macular edema, a condition where fluid accumulates in the central retina and blurs vision. Several case reports have documented this at various dosages.¹¹ Nicotinamide and niacin are not the same molecule, and the glaucoma research focuses on nicotinamide specifically, but the confusion between the two B3 forms is common enough to be worth flagging.

Vitamin D and Elevated Eye Pressure

The evidence linking vitamin D to eye pressure is observational but consistent in direction. A large Korean cross-sectional study found that the proportion of people with elevated IOP was highest in the vitamin D deficiency group (about 3.2%), followed by the insufficiency group (2.4%) and the sufficiency group (1.6%). As blood vitamin D levels increased, the odds of having elevated pressure decreased significantly.¹²

A separate study from the Kangbuk Samsung Health Study in Korea found that the association was sex-specific: women in the fourth quintile of serum vitamin D had about 29% lower odds of glaucoma compared to women in the lowest quintile, but no significant association was found in men.¹³ The reason for this sex difference is not clear, and the finding needs replication in other populations.

Beyond pressure, vitamin D may have a neuroprotective role in glaucoma. A critical review of the literature noted that vitamin D3 could act as a protective factor through its neuroprotective effects, and that deficiency could partly explain glaucoma occurrence or severity in some patients.¹⁴ However, a meta-analysis of vitamin intake and glaucoma risk found no significant association between vitamin D intake and glaucoma prevalence overall.⁶ So the blood-level data and the dietary-intake data tell different stories, possibly because vitamin D comes primarily from sun exposure rather than food, making dietary questionnaires a poor proxy for actual vitamin D status.

Vitamin A, Carotenoids, and Lutein

Vitamin A and its related carotenoids show up in the evidence through two separate pathways. A meta-analysis found that high vitamin A intake was associated with about 37% lower odds of glaucoma.⁶ A systematic review of carotenoids specifically noted a protective trend with greater dietary consumption and reduced glaucoma risk, while higher carotenoid levels in the macular pigment were associated with improved visual performance in glaucomatous eyes.¹⁵

Lutein, a carotenoid found in leafy greens and egg yolks, may contribute through vascular mechanisms rather than direct pressure reduction. A placebo-controlled study of lutein complex supplementation in healthy subjects found significant increases in retinal blood flow and peak blood velocity in the central retinal artery, along with a modest decrease in systemic blood pressure.¹⁶ Improved blood flow to the retina does not lower the number on a tonometer, but it could reduce the vulnerability of optic nerve cells to whatever pressure they face. That said, a population-based U.S. study found that serum levels of vitamin A were not associated with glaucoma prevalence.¹⁷ The discrepancy may reflect the difference between vitamin A itself and the broader family of carotenoids.

Vitamins That Probably Do Not Help

Vitamin E has consistently failed to show a meaningful connection to either IOP or glaucoma risk. The same U.S. population-based study that found no link for vitamin A also found no association between vitamin E supplementation, serum vitamin E levels, and glaucoma prevalence.¹⁷ The meta-analysis confirmed the null result.⁶ If you are taking vitamin E for your eyes, the current evidence suggests it is not doing much for pressure or glaucoma risk specifically.

Vitamin B12 has also come up empty. A prospective study following tens of thousands of participants found no association between B12 intake and the risk of exfoliation glaucoma.¹⁸ Folate showed a more interesting pattern: people in the highest quintile of total folate intake had about 25% lower risk compared to the lowest quintile, though this was a suggestive trend that did not quite reach conventional statistical significance. The association appeared to be driven by supplemental folate rather than dietary folate from food alone.

Botanical and Combination Supplements

Several non-vitamin supplements show up in glaucoma research and are worth mentioning because they are frequently marketed alongside vitamins for eye health. Ginkgo biloba extract has been studied for its effects on ocular blood flow. In healthy volunteers, it increased blood flow velocity in the ophthalmic artery by about 23% without changing IOP or blood pressure.¹⁹ A study in normal-tension glaucoma patients confirmed no significant change in IOP after ginkgo supplementation.²⁰ Ginkgo may improve blood supply to the retina, but it does not appear to lower pressure.

Combination formulas have produced some of the more intriguing results. A product combining French maritime pine bark and bilberry fruit extracts reduced IOP by about 8.7% over four weeks in Japanese patients who already had controlled open-angle glaucoma on standard medication.²¹ A separate formulation called Mirtogenol (a standardized blend of pine bark and bilberry extracts) lowered IOP from about 25 mmHg to 22 mmHg over three months in subjects with borderline high eye pressure, with 19 of 20 patients showing a decrease.²² An animal study of oral Mirtogenol also confirmed significantly reduced IOP in a glaucoma model.²³

Forskolin, derived from the root of the Coleus forskohlii plant, is another compound with intriguing early data. Topical forskolin eye drops at 1% concentration reduced IOP by roughly 4 to 5 mmHg compared to baseline in a small open-label study. Oral forskolin combined with rutin, a flavonoid found in citrus, produced about a further 10% reduction in IOP in patients already on maximum tolerated medical therapy.⁹ These are small studies, but the effect sizes are clinically meaningful if they hold up in larger trials.

Leafy Greens and Dietary Nitrate

Dietary nitrate, found abundantly in spinach, kale, and beets, has a relationship with glaucoma that is worth understanding because it illustrates an important subtlety. A large prospective analysis following nurses and health professionals found that those in the highest quintile of dietary nitrate intake (around 240 mg per day) had about a 21% lower risk of developing open-angle glaucoma compared to those in the lowest quintile.²⁴ The Rotterdam Study confirmed this association, finding that higher nitrate intake was linked to reduced incidence of open-angle glaucoma.²⁵

But here is the catch: neither study found that dietary nitrate was associated with lower IOP. The Rotterdam Study explicitly tested this and found no significant relationship between nitrate intake and pressure measurements.²⁵ The researchers suggested that IOP-independent mechanisms, likely involving improved blood flow and reduced oxidative stress in the optic nerve, may explain the protective effect. This is a useful reminder that “reduces glaucoma risk” and “reduces eye pressure” are not the same claim.

Pressure Reduction Versus Neuroprotection

The research splits neatly into two camps, and conflating them leads to the most common misconception about vitamins and eye pressure. Some nutrients appear to modestly lower IOP directly: vitamin C metabolites through their effect on fluid dynamics, pine bark/bilberry combinations through vascular mechanisms, and forskolin through its action on fluid production. Others protect the optic nerve from damage without changing the pressure number itself: nicotinamide by restoring mitochondrial energy, lutein by improving retinal blood flow, and dietary nitrate through IOP-independent pathways.

Both categories matter to someone worried about glaucoma, because the goal is not really a lower number on a gauge. The goal is preserving vision. Standard glaucoma drugs target pressure because it is the most tractable risk factor, but somewhere between a quarter and half of glaucoma patients continue to lose vision even with well-controlled IOP. Neuroprotective supplements could, in principle, fill that gap. A trial protocol published in 2025 is specifically designed to test whether a vitamin mix can provide neuroprotection alongside standard pressure-lowering therapy, framing it as a potential “low-cost, widely available neuroprotective strategy.”¹⁰

What the Overall Data Show When Pooled

A systematic review and meta-analysis that combined data across multiple observational studies found that high intake of vitamins A and B was associated with significantly lower glaucoma prevalence, with roughly 37% and 29% reduced odds, respectively. Vitamins C, D, and E, however, did not reach statistical significance when the studies were pooled together.⁶ That does not necessarily mean C and D are irrelevant. The individual studies on vitamin C metabolites and vitamin D blood levels were positive, but observational dietary-intake studies are blunt instruments that may miss the real biological exposure. When the data are pooled across studies that measured intake in different ways, the signal can wash out.

The takeaway from the meta-analysis is that vitamins A and B have the most consistent population-level evidence for an association with lower glaucoma risk, while the case for C and D relies more on mechanistic and genetic studies that have not yet been confirmed in large dietary trials.

Practical Considerations and Safety

If you already have glaucoma or ocular hypertension, no supplement should replace your prescribed drops or treatments. The effect sizes seen in supplement studies are modest compared to standard glaucoma medications, which typically lower IOP by 20 to 30% or more. The most encouraging supplement results, like pine bark/bilberry reducing pressure by around 8 to 9%, are in the range of an add-on therapy rather than a primary treatment.

A few practical points are worth keeping in mind:

Form matters: Nicotinamide and niacin are both vitamin B3, but the glaucoma research focuses on nicotinamide. Niacin can cause flushing, liver stress, and in some cases macular edema. Do not substitute one for the other.
Blood levels vs. dietary intake: For vitamins C and D, the research on blood levels and genetic proxies is more encouraging than the research on dietary intake. Getting a blood test for 25-hydroxyvitamin D is straightforward and inexpensive, and knowing your actual status is more useful than guessing from your diet.
Dose uncertainty: The animal studies on nicotinamide used doses that, when scaled to humans, are considerably higher than what you would find in a standard multivitamin. Until human trials establish effective and safe doses, the optimal amount remains unknown.
Combination is the theme: The most promising clinical strategy is not a single vitamin but a combination approach, pairing proven IOP-lowering therapy with nutrients that may offer additional neuroprotection. The ongoing clinical trials are testing this combination model explicitly.

Resveratrol and Topical Nutraceuticals

One area of active research that blurs the line between supplement and medication involves topical application of plant-derived compounds directly to the eye. Topical trans-resveratrol at a 0.2% concentration reduced IOP by up to 25% in a steroid-induced ocular hypertension model, working through adenosine A1 receptor pathways.⁹ That is an impressive effect size, comparable to some pharmaceutical eye drops. Resveratrol is familiar to most people as the compound in red wine, but at pharmacological concentrations delivered topically it behaves more like a drug than a dietary supplement. Whether topical nutraceutical formulations eventually earn a place in clinical practice depends on the results of controlled human trials that have not yet been completed. For now, you cannot walk into a pharmacy and buy resveratrol eye drops with evidence-backed dosing, but the early data suggest this category deserves attention in the coming years.

1
PubMed. The trabecular meshwork outflow pathways: structural and functional aspects
2
PubMed Central. Oxidative stress and antioxidants in the trabecular meshwork
3
PubMed. Oxidative stress in the trabecular meshwork
4
PubMed Central. Ascorbic acid metabolites are involved in intraocular pressure control in the general population
5
PubMed Central. Evaluating vitamin C-related gene-environment and metabolite-environment interaction effects on intraocular pressure in the Canadian Longitudinal Study on Aging
6
Journal Français d’Ophtalmologie. Vitamin intake and glaucoma risk: A systematic review and meta-analysis
7
PubMed Central. Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma
8
PubMed Central. Nicotinamide treatment robustly protects from inherited mouse glaucoma
9
PubMed Central. Vitamins and nutraceuticals in glaucoma research
10
PubMed Central. Interventional Vitamin Mix Glaucoma Study (IVMGS): study protocol for a prospective, randomized, two-arm, single-center trial in existing glaucoma patients
11
PubMed Central. Ocular Effects of Niacin: A Review of the Literature
12
PubMed Central. Inverse Relationship between Serum 25-Hydroxyvitamin D and Elevated Intraocular Pressure
13
PubMed Central. The Relationship between Vitamin D and Glaucoma: A Kangbuk Samsung Health Study
14
Journal of Ophthalmology. Vitamin D and Glaucoma: A Critical Review of the Literature
15
PubMed Central. Carotenoids in the Management of Glaucoma: A Systematic Review of the Evidence
16
PubMed Central. Lutein Complex Supplementation Increases Ocular Blood Flow Biomarkers in Healthy Subjects
17
PubMed Central. Glaucoma and vitamins A, C, and E supplement intake and serum levels in a population-based sample of the United States
18
JAMA Ophthalmology. A Prospective Study of Folate, Vitamin B6, and Vitamin B12 Intake in Relation to Exfoliation Glaucoma or Suspected Exfoliation Glaucoma
19
PubMed. Ginkgo biloba extract increases ocular blood flow velocity
20
PubMed Central. Short-Term Effects of Ginkgo biloba Extract on Peripapillary Retinal Blood Flow in Normal Tension Glaucoma
21
PubMed Central. Effects of French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open-angle glaucoma
22
PubMed Central. Effects of Mirtogenol on ocular blood flow and intraocular hypertension in asymptomatic subjects
23
PubMed Central. Effects of oral Mirtogenol on retinal ganglion cell apoptosis index and intraocular pressure in the Wistar glaucoma model
24
PubMed Central. Association of dietary nitrate intake with primary open-angle glaucoma: a prospective analysis from the Nurses’ Health Study and Health Professionals Follow-up Study
25
PubMed Central. Dietary Nitrate Intake Is Associated with Decreased Incidence of Open-Angle Glaucoma: The Rotterdam Study